These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28073344)

  • 1. Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis.
    Ding P; Li X; Jia Z; Lu Z
    BMC Infect Dis; 2017 Jan; 17(1):57. PubMed ID: 28073344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trend prediction and spatial-temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014-2020.
    Yun W; Huijuan C; Long L; Xiaolong L; Aihua Z
    BMC Infect Dis; 2022 Jun; 22(1):525. PubMed ID: 35672746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time and spatial distribution of multidrug-resistant tuberculosis among Chinese people, 1981-2006: a systematic review.
    Yang XY; Li YP; Mei YW; Yu Y; Xiao J; Luo J; Yang Y; Wu SM
    Int J Infect Dis; 2010 Oct; 14(10):e828-37. PubMed ID: 20570541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-drug resistant spinal tuberculosis-epidemiological characteristics of in-patients: a multicentre retrospective study.
    Yang S; Yu Y; Ji Y; Luo DJ; Zhang ZY; Huang GP; He FY; Wu WJ; Mou XP
    Epidemiol Infect; 2020 Jan; 148():e11. PubMed ID: 31983359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Nourzad S; Jenkins HE; Milstein M; Mitnick CD
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
    Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
    Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of MDR/XDR tuberculosis in coastal plains population of China.
    Yang X; Yuan Y; Pang Y; Wang B; Bai Y; Wang Y; Yu B; Zhang Z; Fan M; Zhao Y
    PLoS One; 2015; 10(2):e0117361. PubMed ID: 25689373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
    Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
    Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey of drug-resistant tuberculosis in China.
    Zhao Y; Xu S; Wang L; Chin DP; Wang S; Jiang G; Xia H; Zhou Y; Li Q; Ou X; Pang Y; Song Y; Zhao B; Zhang H; He G; Guo J; Wang Y
    N Engl J Med; 2012 Jun; 366(23):2161-70. PubMed ID: 22670902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global incidence of multidrug-resistant tuberculosis.
    Zignol M; Hosseini MS; Wright A; Weezenbeek CL; Nunn P; Watt CJ; Williams BG; Dye C
    J Infect Dis; 2006 Aug; 194(4):479-85. PubMed ID: 16845631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
    Pan Y; Yu Y; Yi Y; Dou X; Lu J; Zhou L
    BMC Infect Dis; 2023 Mar; 23(1):162. PubMed ID: 36922787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis.
    Yang Z; Zhou C; Ning Z; Lu W; Zhao Q; Hu Y; Diwan VK; Xu B
    Glob Health Action; 2018; 11(1):1500763. PubMed ID: 30203719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study.
    Ou ZJ; Yu DF; Liang YH; He WQ; Li YZ; Meng YX; Xiong HS; Zhang MY; He H; Gao YH; Wu F; Chen Q
    Infect Dis Poverty; 2021 Mar; 10(1):24. PubMed ID: 33676581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.
    Cohen T; Jenkins HE; Lu C; McLaughlin M; Floyd K; Zignol M
    Drug Resist Updat; 2014; 17(4-6):105-23. PubMed ID: 25458783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
    Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
    J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Drug-Resistant Tuberculosis in Mainland China: An Updated Systematic Review and Meta-Analysis.
    Duan Q; Chen Z; Chen C; Zhang Z; Lu Z; Yang Y; Zhang L
    PLoS One; 2016; 11(2):e0148041. PubMed ID: 26859846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.
    Jenkins HE; Plesca V; Ciobanu A; Crudu V; Galusca I; Soltan V; Serbulenco A; Zignol M; Dadu A; Dara M; Cohen T
    Eur Respir J; 2013 Nov; 42(5):1291-301. PubMed ID: 23100496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.